VIKING GLOBAL INVESTORS LP 13D and 13G filings for Inhibrx Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 5:48 pm Purchase | 2026-03-31 | 13G | INHIBRX BIOSCIENCES INC INBX | VIKING GLOBAL INVESTORS LP | 1,461,633 9.990% | 7,025 (+0.48%) | Filing |
| 2026-02-17 4:26 pm Sale | 2025-12-31 | 13G | INHIBRX BIOSCIENCES INC INBX | VIKING GLOBAL INVESTORS LP | 1,454,608 9.990% | -333,097 (-18.63%) | Filing |
| 2024-06-07 4:23 pm Purchase | 2024-05-29 | 13G | INHIBRX BIOSCIENCES INC INBX | VIKING GLOBAL INVESTORS LP | 1,787,705 12.300% | 1,787,705 (New Position) | Filing |